Literature DB >> 28053347

Functions of bromodomain-containing proteins and their roles in homeostasis and cancer.

Takao Fujisawa1, Panagis Filippakopoulos1,2.   

Abstract

Bromodomains (BRDs) are evolutionarily conserved protein-protein interaction modules that are found in a wide range of proteins with diverse catalytic and scaffolding functions and are present in most tissues. BRDs selectively recognize and bind to acetylated Lys residues - particularly in histones - and thereby have important roles in the regulation of gene expression. BRD-containing proteins are frequently dysregulated in cancer, they participate in gene fusions that generate diverse, frequently oncogenic proteins, and many cancer-causing mutations have been mapped to the BRDs themselves. Importantly, BRDs can be targeted by small-molecule inhibitors, which has stimulated many translational research projects that seek to attenuate the aberrant functions of BRD-containing proteins in disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28053347     DOI: 10.1038/nrm.2016.143

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  162 in total

1.  p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer.

Authors:  Songhui Xu; Lingling Fan; Hee-Young Jeon; Fengbo Zhang; Xiaolu Cui; McKayla B Mickle; Guihong Peng; Arif Hussain; Ladan Fazli; Martin E Gleave; Xuesen Dong; Jianfei Qi
Journal:  Cancer Res       Date:  2020-06-10       Impact factor: 12.701

2.  miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.

Authors:  Yuki Takagawa; Yasuyuki Gen; Tomoki Muramatsu; Kousuke Tanimoto; Jun Inoue; Hiroyuki Harada; Johji Inazawa
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 11.454

3.  Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

Authors:  Luke Erber; Ang Luo; Yue Chen
Journal:  Mol Cell Proteomics       Date:  2019-06-25       Impact factor: 5.911

4.  BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC.

Authors:  Brandon Leonard; Toni M Brand; Rachel A O'Keefe; Eliot D Lee; Yan Zeng; Jacquelyn D Kemmer; Hua Li; Jennifer R Grandis; Neil E Bhola
Journal:  Cancer Res       Date:  2018-05-23       Impact factor: 12.701

Review 5.  Preserving genome integrity and function: the DNA damage response and histone modifications.

Authors:  Jae Jin Kim; Seo Yun Lee; Kyle M Miller
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-06-04       Impact factor: 8.250

6.  Measuring Histone Deacetylase Inhibition in the Brain.

Authors:  Doodipala Samba Reddy; Xin Wu; Victoria M Golub; W Mohaiza Dashwood; Roderick H Dashwood
Journal:  Curr Protoc Pharmacol       Date:  2018-06-07

7.  Double duty: ZMYND8 in the DNA damage response and cancer.

Authors:  Fade Gong; Kyle M Miller
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

8.  RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.

Authors:  Homa Rahnamoun; Jihoon Lee; Zhengxi Sun; Hanbin Lu; Kristen M Ramsey; Elizabeth A Komives; Shannon M Lauberth
Journal:  Nat Struct Mol Biol       Date:  2018-08-03       Impact factor: 15.369

9.  Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.

Authors:  Rezaul Md Karim; Alice Chan; Jin-Yi Zhu; Ernst Schönbrunn
Journal:  J Med Chem       Date:  2020-03-06       Impact factor: 7.446

10.  BET family members Bdf1/2 modulate global transcription initiation and elongation in Saccharomyces cerevisiae.

Authors:  Rafal Donczew; Steven Hahn
Journal:  Elife       Date:  2021-06-17       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.